Should I Buy LQDA? LQDA 2026 Analysis

Should You Buy Liquidia Corp (LQDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

43.040

1 Day change

3.56%

52 Week Range

46.670

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: there is no Intellectia buy signal today and the stock is pulling back (-2.31%) while momentum is starting to cool.
Trend is still broadly bullish (stacked moving averages), but near-term risk/reward is less attractive with heavy insider selling and extremely expensive options implying elevated uncertainty.
A cleaner “buy now” setup would be either a decisive break/hold above 45.80 (R1) or a stronger dip-and-hold near ~42.75 (pivot); at the current 43.70, it’s a hold.

Technical Analysis

Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating an established uptrend.
Momentum: MACD histogram is positive (0.368) but contracting, suggesting bullish momentum is fading rather than accelerating.
RSI (6): 62.51 (neutral-to-slightly-warm), not an oversold dip-buy signal.
Key levels: Pivot 42.749 (near-term support). Resistance at 45.801 (R1) then 47.687 (R2). Support levels at 39.697 (S1) and 37.811 (S2).
Intellectia Proprietary Trading Signals:
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Calls dominate both open interest (call OI 102,778 vs put OI 54,598) and especially volume (put/call volume ratio 0.18) → bullish/optimistic tilt.
Activity: Today’s options volume (8,766) is elevated vs typical levels (today vs 30D avg volume ~39.89), signaling heightened trader engagement.
Volatility: Implied vol 30D ~120.17 vs historical vol ~63.34, with IV percentile ~70.92 → options are very expensive, often seen around uncertainty or event-risk expectations.

Technical Summary

Sell

Buy

Positive Catalysts

- Technical uptrend remains intact (bullish moving-average stack).
- Options market tone is call-skewed (bullish bias).
- Pattern-based projection provided: +3.64% (next week) and +6.64% (next month) median path, suggesting upside bias if trend holds.

Neutral/Negative Catalysts

- Insiders are selling aggressively: selling amount increased 5672.87% over the last month (not supportive of a “buy now” call).
- No recent news catalysts in the past week to justify chasing at current levels.
- Momentum is cooling (MACD histogram still positive but contracting) while the stock is down on the day.
- Extremely high implied volatility (30D ~120%) implies elevated uncertainty and makes options-based bullish bets less attractive on pricing.

Financial Performance

Latest reported quarter: 2025/Q3.
Revenue: 54.342M, up +1121.72% YoY (very strong top-line acceleration).
Profitability: Net income -3.533M (down -84.74% YoY), EPS -0.04 (down -86.67% YoY) → still loss-making and earnings weakened YoY.
Gross margin: 94.16%, up +45.26% YoY → exceptionally strong margin profile in the quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating changes or price target updates were provided in the data, so there is no reliable “Wall Street pros/cons” trend to summarize from this input.
From the available dataset, sentiment inputs are dominated by insider selling (bearish) vs strong revenue growth (bullish), with no explicit Street consensus included.

8 Analyst Rating

Wall Street analysts forecast LQDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LQDA is 47.5 USD with a low forecast of 31 USD and a high forecast of 67 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

8 Buy

0 Hold

0 Sell

Strong Buy

Current: 41.560

Low

Averages

47.5

High

Current: 41.560

Low

Averages

47.5

High

H.C. Wainwright

Buy

maintain

$35 -> $50

AI Analysis

2025-11-04

Reason

H.C. Wainwright

Price Target

$35 -> $50

AI Analysis

2025-11-04

maintain

Buy

Reason

H.C. Wainwright raised the firm's price target on Liquidia to $50 from $35 and keeps a Buy rating on the shares. The firm says the company's profitability "arrived early" with Liquidia reporting "impressive" Q3 earnings. The investment story "has shifted from a binary launch to a profit driven story," the analyst tells investors in a research note.

Raymond James

Strong Buy

maintain

$41 -> $47

2025-11-04

Reason

Raymond James

Price Target

$41 -> $47

2025-11-04

maintain

Strong Buy

Reason

Raymond James raised the firm's price target on Liquidia to $47 from $41 and keeps a Strong Buy rating on the shares. Liquidia's Q3 earnings were driven by strong Yutrepia performance in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, with net sales of $51.7M, over triple consensus estimates, and profitability achieved ahead of schedule, the analyst tells investors in a research note. Yutrepia accounted for roughly 75% of revenue growth in its market, aided by major PBM contracts and easing new-patient restrictions. Unadjusted peak sales estimates have been raised to about $2B from $1.1B, reflecting exceptional early launch momentum.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LQDA

Unlock Now

LQDA Should I Buy

LQDA Should I Buy

Should You Buy Liquidia Corp (LQDA) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch